<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34487633</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2162-3279</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Brain and behavior</Title>
          <ISOAbbreviation>Brain Behav</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Seasonality in the incidence of anti-GQ1b antibody syndrome-A territory-wide study.</ArticleTitle>
        <Pagination>
          <StartPage>e2337</StartPage>
          <MedlinePgn>e2337</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e2337</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.2337</ELocationID>
        <Abstract>
          <AbstractText Label="AIMS">To investigate any seasonality in the incidence of anti-GQ1b antibody syndrome (AGS).</AbstractText>
          <AbstractText Label="METHODS">We conducted a retrospective observational study in all hospitalized patients in local public hospitals from January 2013 to December 2018. AGS was defined by hospitalized patients with positive serum anti-GQ1b IgG, presumably encompassing Miller-Fisher syndrome, Bickerstaff brainstem encephalitis and Guillain-Barré syndrome (GBS) variants. GBS cases were retrieved from the computerized database by diagnostic label. Campylobacter jejuni infection (CJI) injection was identified by positive stool culture. Monthly incidence rates of AGS, GBS and CJI were calculated. Poisson and negative binomial regression models with long-term time trend were fitted to characterize the seasonal pattern.</AbstractText>
          <AbstractText Label="RESULTS">A total of 237, 572 and 2434 cases of AGS, GBS and CJI were identified, respectively, in a population of 7.3 million. The annual incidence rate of AGS was 0.54 per 100,000 person-years. AGS was demonstrated to have an annual peak in the spring season, from March to April, which was congruent with that of GBS and slightly lagged the annual peak of CJI from February to March (likelihood ratio tests all p &lt; .001 for the seasonal terms).</AbstractText>
          <AbstractText Label="CONCLUSION">The incidence of AGS peaks in springtime, which is congruent with that of GBS and lags around one month after that of CJI. We demonstrated that AGS has a clear seasonality in occurrence.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Richard Shek-Kwan</ForeName>
            <Initials>RS</Initials>
            <Identifier Source="ORCID">0000-0002-9346-3877</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Neurology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lau</LastName>
            <ForeName>Eric H Y</ForeName>
            <Initials>EHY</Initials>
            <AffiliationInfo>
              <Affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Au</LastName>
            <ForeName>Elaine Yuen Ling</ForeName>
            <Initials>EYL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leung</LastName>
            <ForeName>William C Y</ForeName>
            <Initials>WCY</Initials>
            <Identifier Source="ORCID">0000-0001-7363-0239</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Neurology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Leung</LastName>
            <ForeName>Yu Hin Ian</ForeName>
            <Initials>YHI</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neurology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D064888">Observational Study</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>09</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Brain Behav</MedlineTA>
        <NlmUniqueID>101570837</NlmUniqueID>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D005732">Gangliosides</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005732" MajorTopicYN="N">Gangliosides</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020275" MajorTopicYN="Y">Guillain-Barre Syndrome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019846" MajorTopicYN="Y">Miller Fisher Syndrome</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Guillain-Barré syndrome</Keyword>
        <Keyword MajorTopicYN="Y">anti-GQ1b antibody syndrome</Keyword>
        <Keyword MajorTopicYN="Y">epidemiology</Keyword>
        <Keyword MajorTopicYN="Y">neuropathy</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>6</Day>
          <Hour>17</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34487633</ArticleId>
        <ArticleId IdType="pmc">PMC8553321</ArticleId>
        <ArticleId IdType="doi">10.1002/brb3.2337</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>

Allos, B. M.
 (2001). 
Campylobacter jejuni infections: Update on emerging issues and trends. Clinical Infectious Diseases, 32(8), 1201–1206
10.1086/319760
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/319760</ArticleId>
            <ArticleId IdType="pubmed">11283810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Authority, T. H.
 (2019). Hospital authority statistical report 2012–2013. http://www.ha.org.hk/haho/ho/stat/HASR1415_2.pdf
</Citation>
        </Reference>
        <Reference>
          <Citation>

Bickerstaff, E. R.
 (1957). Brain‐stem encephalitis; further observations on a grave syndrome with benign prognosis. British Medical Journal, 1(5032), 1384–1387. 10.1136/bmj.1.5032.1384
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.1.5032.1384</ArticleId>
            <ArticleId IdType="pmc">PMC1973653</ArticleId>
            <ArticleId IdType="pubmed">13436795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bickerstaff, E. R.
, &amp; 
Cloake, P. C.
 (1951). Mesencephalitis and rhombencephalitis. British Medical Journal, 2(4723), 77–81. 10.1136/bmj.2.4723.77
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.2.4723.77</ArticleId>
            <ArticleId IdType="pmc">PMC2069534</ArticleId>
            <ArticleId IdType="pubmed">14848512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Breman, J. G.
, &amp; 
Hayner, N. S.
 (1984). Guillain‐Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976–1977. American Journal of Epidemiology, 119(6), 880–889. 10.1093/oxfordjournals.aje.a113810
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.aje.a113810</ArticleId>
            <ArticleId IdType="pubmed">6731430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Census and Statistics Department
. (2019). The Government of the Hong Kong Special Administrative Region. https://www.censtatd.gov.hk/hkstat/sub/so20.jsp
</Citation>
        </Reference>
        <Reference>
          <Citation>

Chan, E. W.
, 
Lau, W. C. Y.
, 
Leung, W. K.
, 
Mok, M. T. C.
, 
He, Y.
, 
Tong, T. S. M.
, &amp; 
Wong, I. C. K.
 (2015). Prevention of dabigatran‐related gastrointestinal bleeding with gastroprotective agents: A population‐based study. Gastroenterology, 149(3), 586–595.e3. 10.1053/j.gastro.2015.05.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2015.05.002</ArticleId>
            <ArticleId IdType="pubmed">25960019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Chen, Z.
, 
Liew, D.
, &amp; 
Kwan, P.
 (2014). Effects of a HLA‐B*15:02 screening policy on antiepileptic drug use and severe skin reactions. Neurology, 83(22), 2077–2084
10.1212/WNL.0000000000001034
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000001034</ArticleId>
            <ArticleId IdType="pubmed">25355835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Cheung, N. T.
, 
Fung, V.
, &amp; 
Kong, J. H.
 (2004). The Hong Kong Hospital Authority's information architecture. Studies in Health Technology and Informatics, 107(Pt 2), 1183–1186. 10.3233/978-1-60750-949-3-1183
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/978-1-60750-949-3-1183</ArticleId>
            <ArticleId IdType="pubmed">15360999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Chiba, A.
, 
Kusunoki, S.
, 
Obata, H.
, 
Machinami, R.
, &amp; 
Kanazawa, I.
 (1993). Serum anti‐GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome: Clinical and immunohistochemical studies. Neurology, 43(10), 1911–1917. 10.1212/WNL.43.10.1911
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.43.10.1911</ArticleId>
            <ArticleId IdType="pubmed">8413947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Chiu, S. S.
, 
Lau, Y. L.
, 
Chan, K. H.
, 
Wong, W. H. S.
, &amp; 
Peiris, J. S. M.
 (2002). Influenza‐related hospitalizations among children in Hong Kong. New England Journal of Medicine, 347(26), 2097–2103. 10.1056/NEJMoa020546
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa020546</ArticleId>
            <ArticleId IdType="pubmed">12501221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Fisher, M.
 (1956). An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). New England Journal of Medicine, 255(2), 57–65. 10.1056/NEJM195607122550201
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM195607122550201</ArticleId>
            <ArticleId IdType="pubmed">13334797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Hadden, R. D. M.
, 
Cornblath, D. R.
, 
Hughes, R. A. C.
, 
Zielasek, J.
, 
Hartung, H.‐P.
, 
Toyka, K. V.
, &amp; 
Swan, A. V.
 (1998). Electrophysiological classification of Guillain‐Barré syndrome: Clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group. Annals of Neurology, 44(5), 780–788. 10.1002/ana.410440512
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.410440512</ArticleId>
            <ArticleId IdType="pubmed">9818934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ho, B. S.
, &amp; 
Wong, W. T.
 (1985). A one‐year survey of campylobacter enteritis and other forms of bacterial diarrhoea in Hong Kong. Journal of Hygiene, 94(1), 55–60. 10.1017/s002217240006112x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/s002217240006112x</ArticleId>
            <ArticleId IdType="pmc">PMC2129398</ArticleId>
            <ArticleId IdType="pubmed">3973381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Houliston, R. S.
, 
Koga, M.
, 
Li, J.
, 
Jarrell, H. C.
, 
Richards, J. C.
, 
Vitiazeva, V.
, 
Schweda, E. K. H.
, 
Yuki, N.
, &amp; 
Gilbert, M.
 (2007). A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry, 46(27), 8164–8171. 10.1021/bi700685s
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bi700685s</ArticleId>
            <ArticleId IdType="pubmed">17567050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Hui, A. C. F.
, 
Chow, K. M.
, 
Tang, A. S. Y.
, 
Fu, M.
, 
Kay, R.
, &amp; 
Wong, K.
 (2005). Electrophysiological, clinical and epidemiological study of Guillain‐Barré Syndrome in Hong Kong Chinese. Journal of Clinical Neuroscience, 12(2), 134–136
10.1016/j.jocn.2003.10.018
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2003.10.018</ArticleId>
            <ArticleId IdType="pubmed">15749412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kimoto, K.
, 
Koga, M.
, 
Odaka, M.
, 
Hirata, K.
, 
Takahashi, M.
, 
Li, J.
, 
Gilbert, M.
, &amp; 
Yuki, N.
 (2006). Relationship of bacterial strains to clinical syndromes of Campylobacter‐associated neuropathies. Neurology, 67(10), 1837–1843. 10.1212/01.wnl.0000244468.22377.6b
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/01.wnl.0000244468.22377.6b</ArticleId>
            <ArticleId IdType="pubmed">17130419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Lake, I. R.
, &amp; 
Barker, G. C.
 (2018). Climate change, foodborne pathogens and illness in higher‐income countries. Current Environmental Health Report, 5(1), 187–196. 10.1007/s40572-018-0189-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40572-018-0189-9</ArticleId>
            <ArticleId IdType="pmc">PMC5876342</ArticleId>
            <ArticleId IdType="pubmed">29446033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Louis, V. R.
, 
Gillespie, I. A.
, 
O'brien, S. J.
, 
Russek‐Cohen, E.
, 
Pearson, A. D.
, &amp; 
Colwell, R. R.
 (2005). Temperature‐driven Campylobacter seasonality in England and Wales. Applied and Environmental Microbiology, 71(1), 85–92. 10.1128/AEM.71.1.85-92.2005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.71.1.85-92.2005</ArticleId>
            <ArticleId IdType="pmc">PMC544220</ArticleId>
            <ArticleId IdType="pubmed">15640174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Lyu, R.‐K.
, 
Tang, L.‐M.
, 
Cheng, S.‐Y.
, 
Hsu, W.‐C.
, &amp; 
Chen, S.‐T.
 (1997). Guillain‐Barré syndrome in Taiwan: A clinical study of 167 patients. Journal of Neurology, Neurosurgery, and Psychiatry, 63(4), 494–500. 10.1136/jnnp.63.4.494
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.63.4.494</ArticleId>
            <ArticleId IdType="pmc">PMC2169759</ArticleId>
            <ArticleId IdType="pubmed">9343130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ma, Y. M.
, 
Liu, T. K.
, &amp; 
Wong, V.
 (2010). Guillain‐Barré syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatrics International, 52(1), 13–9
10.1111/j.1442-200X.2009.02951.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1442-200X.2009.02951.x</ArticleId>
            <ArticleId IdType="pubmed">19702649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

McGechie, D. B. T.
, &amp; 
TB, B. V. M.
 (1982). Campylobacter enteritis in Hong Kong and Western Australia. In D. G.

Newell (Ed.), Campylobacter, epidemiology, pathogenesis, and biochemistry (pp. 19–21). Springer Science &amp; Business Media.</Citation>
        </Reference>
        <Reference>
          <Citation>

Mori, M.
, 
Kuwabara, S.
, 
Fukutake, T.
, 
Yuki, N.
, &amp; 
Hattori, T.
 (2001). Clinical features and prognosis of Miller Fisher syndrome. Neurology, 56(8), 1104–1106. 10.1212/WNL.56.8.1104
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.56.8.1104</ArticleId>
            <ArticleId IdType="pubmed">11320188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Nishimoto, Y.
, 
Odaka, M.
, 
Hirata, K.
, &amp; 
Yuki, N.
 (2004). Usefulness of anti‐GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. Journal of Neuroimmunology, 148(1–2), 200–205. 10.1016/j.jneuroim.2003.11.017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2003.11.017</ArticleId>
            <ArticleId IdType="pubmed">14975602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Odaka, M.
, 
Yuki, N.
, &amp; 
Hirata, K.
 (2001). Anti‐GQ1b IgG antibody syndrome: Clinical and immunological range. Journal of Neurology, Neurosurgery, and Psychiatry, 70(1), 50–5. 10.1136/jnnp.70.1.50
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.70.1.50</ArticleId>
            <ArticleId IdType="pmc">PMC1763462</ArticleId>
            <ArticleId IdType="pubmed">11118247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Shahrizaila, N.
, &amp; 
Yuki, N.
 (2013). Bickerstaff brainstem encephalitis and Fisher syndrome: Anti‐GQ1b antibody syndrome. Journal of Neurology, Neurosurgery, and Psychiatry, 84(5), 576–853. 10.1136/jnnp-2012-302824
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2012-302824</ArticleId>
            <ArticleId IdType="pubmed">22984203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Shoamanesh, A.
, 
Chapman, K.
, &amp; 
Traboulsee, A.
 (2011). Postvaccination Miller Fisher syndrome. Archives of Neurology, 68(10), 1327–1329. 10.1001/archneurol.2011.236
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneurol.2011.236</ArticleId>
            <ArticleId IdType="pubmed">21987549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Smith, B. A.
, &amp; 
Fazil, A.
 (2019). How will climate change impact microbial foodborne disease in Canada?
Canada Communicable Disease Report, 45(4), 108–113. 10.14745/ccdr.v45i04a05
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14745/ccdr.v45i04a05</ArticleId>
            <ArticleId IdType="pmc">PMC6587690</ArticleId>
            <ArticleId IdType="pubmed">31285700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Stowe, J.
, 
Andrews, N.
, 
Wise, L.
, &amp; 
Miller, E.
 (2009). Investigation of the temporal association of Guillain‐Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. American Journal of Epidemiology, 169(3), 382–388. 10.1093/aje/kwn310
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwn310</ArticleId>
            <ArticleId IdType="pubmed">19033158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Tang, X.
, 
Zhao, S.
, 
Chiu, A. P. Y.
, 
Wang, X.
, 
Yang, L.
, &amp; 
He, D.
 (2017). Analysing increasing trends of Guillain‐Barré Syndrome (GBS) and dengue cases in Hong Kong using meteorological data. Plos One, 12(12), e0187830. 10.1371/journal.pone.0187830
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0187830</ArticleId>
            <ArticleId IdType="pmc">PMC5714337</ArticleId>
            <ArticleId IdType="pubmed">29200423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Webb, A. J. S.
, 
Brain, S. A. E.
, 
Wood, R.
, 
Rinaldi, S.
, &amp; 
Turner, M. R.
 (2015). Seasonal variation in Guillain‐Barré syndrome: A systematic review, meta‐analysis and Oxfordshire cohort study. Journal of Neurology, Neurosurgery, and Psychiatry, 86(11), 1196–1201. 10.1136/jnnp-2014-309056
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2014-309056</ArticleId>
            <ArticleId IdType="pubmed">25540247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Weinberger, M.
, 
Lerner, L.
, 
Valinsky, L.
, 
Moran‐Gilad, J.
, 
Nissan, I.
, 
Agmon, V.
, &amp; 
Peretz, C.
 (2013). Increased incidence of Campylobacter spp. infection and high rates among children, Israel. Emerging Infectious Diseases, 19(11), 1828–1831. 10.3201/eid1911.120900
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1911.120900</ArticleId>
            <ArticleId IdType="pmc">PMC3837641</ArticleId>
            <ArticleId IdType="pubmed">24188185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yuan, C. L.
, 
Wang, Y. J.
, &amp; 
Tsai, C. P.
 (2000). Miller fisher syndrome: A hospital‐based retrospective study. European Neurology, 44(2), 79–85. 10.1159/000008201
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000008201</ArticleId>
            <ArticleId IdType="pubmed">10965158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yuki, N.
 (2001). Infectious origins of, and molecular mimicry in, Guillain‐Barré and Fisher syndromes. The Lancet Infectious Diseases, 1(1), 29–37. 10.1016/S1473-3099(01)00019-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(01)00019-6</ArticleId>
            <ArticleId IdType="pubmed">11871407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yuki, N.
, 
Sato, S.
, 
Tsuji, S.
, 
Hozumi, I.
, &amp; 
Miyatake, T.
 (1993). An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. Journal of the Neurological Sciences, 118(1), 83–87. 10.1016/0022-510X(93)90250-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-510X(93)90250-3</ArticleId>
            <ArticleId IdType="pubmed">8229054</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
